Patent details

LUC00250 Product Name: Zanubrutinib ou un de ses sels pharmaceutiquement acceptables

Basic Information

Publication number:
LUC00250
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP147876429
Legal Status:
Inactive
Application number:
LUC00250
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/21/1576
Marketing Authorization Type:
Marketing Authorization Date:
23/11/2021
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
11/03/2022
First Marketing Authorization date:
23/11/2021
Grant date:
04/03/2025
Activation date:
Publication date:
11/03/2022
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
23/11/2036
SPC Extension Expiration:
23/11/2036
Rejection date:
Withdrawal date:

Owner

From:
14/08/2025
 
 

Name:
BeOne Medicines I GmbH
Address:
Aeschengraben 27, 4051, Basel, Switzerland (CH)

History of Owners

From:
21/09/2023
To:
14/08/2025

Name:
BeiGene Switzerland GmbH
Address:
Aeschengraben 27, 4051, Basel , Switzerland (CH)

From:
11/03/2022
To:
21/09/2023

Name:
Beigene Ltd.
Address:
94 Solaris Avenue PO Box 1348 George Town, Grand Cayman KY1-1108, Cayman Islands (KY)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
11/03/2022
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2022/05
Publication date:
01/04/2022
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
CO
Bulletin edition number:
2023/11
Publication date:
05/10/2023
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

3

Bulletin Heading:
SPC2
Bulletin edition number:
2025/05
Publication date:
07/04/2025
Description:
Section D : Granted supplementary protection certificates – I2 publication

4

Bulletin Heading:
CO
Bulletin edition number:
2025/10
Publication date:
05/09/2025
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20230000396A
Date Registered:
21/09/2023
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
BeiGene Switzerland GmbH
Address:
Aeschengraben 27, 4051, Basel , Switzerland (CH)

Removed Pledgee

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20250000291A
Date Registered:
14/08/2025
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Changement de nom
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
BeOne Medicines I GmbH
Address:
Aeschengraben 27, 4051, Basel, Switzerland (CH)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
01/05/2034
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
11/03/2022 Outgoing Correspondence 1
14/08/2025 Request For Change 4
19/08/2025 Outgoing Correspondence 1
11/03/2022 Publication 1
04/03/2025 Publication 1
04/03/2025 Certificate 1
04/03/2025 Outgoing Correspondence 1
11/03/2022 MA publication 2
21/09/2023 Request For Change 7
21/09/2023 Outgoing Correspondence 1
11/03/2022 Application Form 3
11/03/2022 Marketing authorization 3
11/03/2022 Summary of the product caracteristics 32